Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Drug Discovery

Background:

• Human Immunodeficiency Virus type 1 (HIV-1) protease is a critical target for antiviral therapy.
• Developing potent and bioavailable inhibitors remains a key challenge in HIV-1 treatment.
• Phosphinic acids offer a promising scaffold for designing enzyme inhibitors.

Purpose of the Study:

• To develop an efficient synthesis for diverse symmetrical phosphinic acids.
• To design novel HIV-1 protease inhibitors with enhanced potency and bioavailability.
• To explore esterification strategies for improving drug absorption and introducing beneficial moieties.

Main Methods:

• Synthesis of symmetrical phosphinic acids using peptide coupling reagents (TBTU, DIC).
• Design of elongated analogues based on enzyme-substrate specificity.
• Esterification of phosphinic acids with carbohydrates and flavonoids.

Main Results:

• Achieved excellent to quantitative yields in phosphinic acid synthesis.
• Designed compounds demonstrated significant inhibition of HIV-1 protease (low nanomolar IC50 values).
• Developed esterification protocol yielding low-toxicity compounds with potential for in situ generation of hepatoprotective flavonoids or carbohydrate metabolites.

Conclusions:

• The developed methodology provides a versatile route to novel phosphinic acid-based HIV-1 protease inhibitors.
• Esterification enhances drug delivery and introduces beneficial pharmacological properties.
• This research offers a promising strategy for developing next-generation HIV-1 therapeutics.